Empresas y finanzas

Press Alert: Boehringer Ingelheim to Raise Awareness of Women in Cardiovascular Disease and Thrombosis

For media outside of the US, the UK & Canada only

What: Join key experts in cardiology and thrombosis for a special TweetChat (#ChatAFib), live from the ESC Congress 2013 (#ESCcongress2013) in Amsterdam, which is organised by the European Society of Cardiology

We will be discussing:

  • Key issues around awareness of cardiovascular disease and thrombosis in women
  • How common is antithrombotic treatment use in women versus men?
  • Are women more likely than men to become disabled by an AF-related stroke?
  • Management of women, cardiovascular disease and thrombosis in daily clinical practice

Who:

  • Prof. Angela Maas, Professor of Cardiology for Women, UMC, St. Radboud, The Netherlands
  • Dr. Yolande Appelman, Chair of the Working Group on Gender, The Netherlands Society of Cardiology and Interventional Cardiologist at VUmc
  • Patient Advocacy Group representatives including Mellanie True Hills from StopAFib.org and De Hart & Vaatgroep

When: 15:00 - 16:00 CET, Monday 2nd September

How: This is a bilingual TweetChat. To join the conversation in English follow #ChatAFib, to join the conversation in Dutch follow #Hartenvaat

On Twitter

Follow @boehringer and @boehringernl for updates and information

 

WhatsAppFacebookFacebookTwitterTwitterLinkedinLinkedinBeloudBeloudBluesky